A Nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy
Sun, Min, Liu, Xiaoxiao, Xia, Lingyun, Chen, Yuying, Kuang, Li, Gu, Xinsheng, Li, TianJournal:
Biochemical Pharmacology
DOI:
10.1016/j.bcp.2020.114285
Date:
October, 2020
File:
PDF, 999 KB
2020